EXEL vs QGEN
Exelixis, Inc. and Qiagen N.v., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | EXEL | QGEN |
|---|---|---|
| Revenue | $2.3B | $2.1B |
| Net income | $782.6M | $424.9M |
| Gross margin | 96.4% | 62.2% |
| Net margin | 33.7% | 20.3% |
| Return on equity | 35.5% | 11.6% |
| Diluted EPS | $2.78 | $1.94 |
| Dividend / share | · | $0.25 |
| Payout ratio | · | 12.8% |
| Free cash flow | $875.8M | $453.3M |
| Equity | $2.2B | $3.8B |
| Net debt / equity | · | 0.22× |
| Current ratio | 3.56× | 3.90× |
| Revenue CAGR 5y | 18.6% | 2.2% |
| Profit CAGR 5y | 47.6% | 3.4% |
EXEL and QGEN book revenue within 15% of each other, and keeps more of each dollar of revenue as profit (33.7% against 20.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | EXEL | QGEN |
|---|---|---|
| FY2025 | $2.3B | $2.1B |
| FY2024 | $2.2B | $2.0B |
| FY2023 | $1.8B | $2.0B |
| FY2022 | $1.6B | $2.1B |
| FY2021 | $1.4B | $2.3B |
| FY2020 | $987.5M | $1.9B |
| FY2019 | $967.8M | $1.5B |
| FY2018 | $853.8M | $1.5B |
| FY2017 | $452.5M | $1.4B |
| FY2016 | $191.5M | $1.3B |
Bottom line
| Fiscal year | EXEL | QGEN |
|---|---|---|
| FY2025 | $782.6M | $424.9M |
| FY2024 | $521.3M | $83.6M |
| FY2023 | $207.8M | $341.3M |
| FY2022 | $182.3M | $423.2M |
| FY2021 | $231.1M | $512.6M |
| FY2020 | $111.8M | $359.2M |
| FY2019 | $321.0M | $-41.5M |
| FY2018 | $690.1M | $190.4M |
| FY2017 | $154.2M | $40.4M |
| FY2016 | $-70.2M | $80.4M |
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$230,127,000 | EXEL |
| FY2024 | +$190,487,000 | EXEL |
| FY2023 | −$135,103,000 | QGEN |
| FY2022 | −$530,456,000 | QGEN |
| FY2021 | −$816,687,000 | QGEN |
| FY2020 | −$882,808,000 | QGEN |
| FY2019 | −$558,649,000 | QGEN |
| FY2018 | −$648,022,000 | QGEN |
| FY2017 | −$965,059,000 | QGEN |
| FY2016 | −$1,146,537,000 | QGEN |
| FY2015 | −$1,243,814,000 | QGEN |
| FY2014 | −$1,319,666,000 | QGEN |
| FY2013 | −$1,270,646,000 | QGEN |
| FY2012 | −$1,207,006,000 | QGEN |
| FY2011 | −$880,111,000 | QGEN |
| FY2010 | −$902,386,000 | QGEN |
| FY2009 | −$858,066,000 | QGEN |
The higher-revenue side has changed between EXEL and QGEN over this period. The gap has narrowed since the earliest year compared.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +13.4 pp | EXEL |
| FY2024 | +19.8 pp | EXEL |
| FY2023 | −6.0 pp | QGEN |
| FY2022 | −8.4 pp | QGEN |
| FY2021 | −6.7 pp | QGEN |
| FY2020 | −7.9 pp | QGEN |
| FY2019 | +35.9 pp | EXEL |
| FY2018 | +68.1 pp | EXEL |
| FY2017 | +31.2 pp | EXEL |
| FY2016 | −42.7 pp | QGEN |
| FY2015 | −445.3 pp | QGEN |
| FY2014 | −1049.3 pp | QGEN |
| FY2013 | −765.4 pp | QGEN |
| FY2012 | −316.6 pp | QGEN |
| FY2011 | +18.0 pp | EXEL |
| FY2010 | −63.2 pp | QGEN |
| FY2009 | −102.7 pp | QGEN |
The higher net margin has changed hands between EXEL and QGEN over this period.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
EXEL's net margin has been more volatile than QGEN's over the 17 comparable fiscal years — 308.5 percentage points of standard deviation against 6.8.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between EXEL and QGEN over these 17 fiscal years — EXEL led in 6 and QGEN in 11.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
EXEL's return on equity has been more volatile than QGEN's over the 11 comparable fiscal years — 74.1 percentage points of standard deviation against 5.7.
11 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between EXEL and QGEN over these 11 fiscal years — EXEL led in 5 and QGEN in 6.
11 of 18 comparable fiscal years — a year missing data on either side is not counted.